Patent Assignment
Reel/Frame 058446/0758
Assignment of Assignor's Interest
Recorded: 2021-12-21
Pages: 8
Assignor
FORMULATION TECHNOLOGIES, LLC DBA PHARMAFORM
Executed: 2008-07-17
Assignee
HIGHLAND THERAPEUTICS INC.
72 SAULTER STREET, TORONTO, ONTARIO, M4M 2H7, CANADA
Covered Properties
(2)
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Application:
17/557,476 →
Publication:
US 2022/0110877
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 21, 2021
From: LICKRISH, DAVID
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 058445/0530 →
Assignment of Assignor's Interest
Dec 21, 2021
From: ZHANG, FENG
To: FORMULATION TECHNOLOGIES, LLC DBA PHARMAFORM
Reel/Frame 058446/0644 →
Assignment of Assignor's Interest
Dec 21, 2021
From: HIGHLAND THERAPEUTICS INC.
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 058446/0846 →
Patent Security Agreement
Sep 3, 2024
From: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 068826/0711 →
Release of Security Interest
Dec 23, 2025
From: BIOPHARMA CREDIT PLC
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 073308/0416 →
Security Interest
Dec 23, 2025
From: COLLEGIUM PHARMACEUTICAL, INC.; BIODELIVERY SCIENCES INTERNATIONAL, INC.; IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
To: TRUIST BANK, A NORTH CAROLINA CHARTERED BANK
Reel/Frame 073302/0334 →